The Effect of Brain Stimulation (tDCS) in Food Cravings Control in Overweight/Obese Women
The Effect of Brain Neuromodulation on Food Cravings, Cognitive Control and Food Addiction Scales in Overweight/Obese Women Using tDCS
1 other identifier
interventional
30
1 country
1
Brief Summary
This study is a randomized clinical trial to test the effect of a type of non-invasive brain stimulation on the response to a behavioral intervention designed to enhance cognitive control over food cravings in obese and overweight women. The brain stimulation is called transcranial Direct Current Stimulation (tDCS). All eligible participants will engage in a behavioral intervention known to enhance control over food cravings and will be randomly assigned to receive either tDCS or sham stimulation to the prefrontal cortex of the brain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Jan 2017
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2017
CompletedFirst Submitted
Initial submission to the registry
April 21, 2017
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJune 9, 2020
June 1, 2020
4.4 years
April 21, 2017
June 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Yale Food Addiction Scale scores
Yale Food Addiction Scale (YFAS26) that is a 25-item measure developed to measure food addiction. Score range: 0 to 7. Higher scores in the scale mean more symptoms resembling food addiction (worse).
Scores measured at baseline and at up-to 2 weeks after the intervention
Change in Three-Factor Eating Questionnaire scores
Three-Factor Eating Questionnaire is a validated scale that is designed to measure 3 dimensions of human eating behavior: cognitive restraint of eating (Factor I), disinhibition (Factor II), and hunger (Factor III). The minimum score for factors I-II-III is therefore 0-0-0, and maximum possible score is 20-16-15. Higher scores in the respective scales are indicative of greater cognitive restraint (better), uncontrolled (worse), or emotional eating (worse).
Scores measured at baseline and at up-to 2 weeks after the intervention
Secondary Outcomes (2)
Change in brain neural activity by functional Magnetic Resonance Imaging ( fMRI)
Brain function at baseline and up-to 2 weeks after the intervention
Change in Brain metabolites concentrations by Magnetic Resonance Spectroscopy (MRS)
Brain MRS at baseline and up-to 2 weeks after the intervention
Other Outcomes (4)
Diet (3-day food intake record)
Values measured at baseline and at up-to 2 weeks after the intervention
Change in Yale Food Addiction Scale scores at 3-months post-intervention
At 3-months after intervention
Change in Three-Factor Eating Questionnaire scores at 3-months post-intervention
At 3-months after intervention
- +1 more other outcomes
Study Arms (2)
tDCS and Go-No Go task
EXPERIMENTALCertain randomly assigned participants will receive tDCS to the DLPFC for 8 daily 20-minute sessions, with a TDCS amplitude of 2 mAmps. During the tDCS session, individuals will perform a 10-min computerized Go-No Go task
Sham brain stimulation and Go-No Go task
SHAM COMPARATORCertain randomly assigned participants will receive Sham Stimulation to the DLPFC for 8 daily 20-min sessions. The Sham stimulation is an inactive form of stimulation. During the sham brain stimulation session, individuals will perform a 10-min computerized Go-No Go task
Interventions
Individuals undergo 20min daily sessions receiving actual tDCS to the brain (to the right DLPFC: dorsolateral prefrontal cortex)
Individuals undergo 20min daily sessions receiving sham stimulation to the brain (to the right DLPFC: dorsolateral prefrontal cortex)
During the brain stimulation sessions, all individuals will be asked to perform a 10 min-computerized task related to inhibitory control (Go-No Go)
Eligibility Criteria
You may qualify if:
- BMI between 28 and 40 kg/m2 high scores in the Yale-Food Addiction-Scale right-handed
You may not qualify if:
- History of anorexia nervosa or bulimia or binge eating disorder
- Any contraindication to undergo MRI
- Use of psychotropic medications and/or opiate pain medications.
- Current or past alcohol or drug abuse problem or smoking
- Pregnancy
- Current use of weight loss medication or currently participating in a weight loss program.
- History of seizures, epilepsy or factors/medications associated with lowered seizure threshold.
- History of brain disease or major neurological disorder or mental disorder
- History of brain surgery or history of loss of consciousness \>15 min
- History of major gastrointestinal surgery including weight loss surgery
- History of endocrine imbalances including diabetes, thyroid disease, Cushing's disease, metabolic syndrome and polycystic ovary.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudia P Sanmiguel, MD
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Health Sciences Assistant Professor
Study Record Dates
First Submitted
April 21, 2017
First Posted
June 9, 2020
Study Start
January 4, 2017
Primary Completion
May 31, 2021
Study Completion
December 31, 2021
Last Updated
June 9, 2020
Record last verified: 2020-06